Qube Research & Technologies (QRT)’s Caribou Biosciences CRBU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$961K	Buy	545,755 +369,058	+209%	+$729K	﹤0.01%	2431
2026 Q1	$336K	Sell	176,697 -27,955	-14%	-$48K	﹤0.01%	2846
2025 Q4	$325K	Buy	204,652 +159,502	+353%	+$335K	﹤0.01%	2926
2025 Q3	$105K	Buy	+45,150	New	+$85.2K	﹤0.01%	3054
2024 Q3	–	Sell	-220,017	Closed	-$361K	–	3435
2024 Q2	$361K	Buy	+220,017	New	+$703K	﹤0.01%	2244
2023 Q3	–	Sell	-83,612	Closed	-$355K	–	4120
2023 Q2	$355K	Buy	+83,612	New	+$376K	﹤0.01%	1616
2023 Q1	–	Sell	-24,025	Closed	-$151K	–	2601
2022 Q4	$151K	Buy	+24,025	New	+$214K	﹤0.01%	1895
2022 Q3	–	Sell	-14,326	Closed	-$78K	–	2568
2022 Q2	$78K	Sell	14,326 -35,932	-71%	-$275K	﹤0.01%	2020
2022 Q1	$461K	Buy	+50,258	New	+$530K	﹤0.01%	1571

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRBU Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Caribou Biosciences (CRBU) stake by 209% in Q2 2026, buying an estimated $729K and bringing the position to 545,755 shares worth $961K. The position accounts for ﹤0.01% of the portfolio, ranked #2431.

Qube Research & Technologies (QRT) first reported a position in CRBU in Q1 2022 and has held it in 9 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Qube Research & Technologies (QRT) held 545,755 shares of Caribou Biosciences worth $961K as of Q2 2026.
Qube Research & Technologies (QRT) bought 369,058 Caribou Biosciences shares in Q2 2026, an estimated $729K.
Caribou Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2431 holding.
Qube Research & Technologies (QRT) first reported a position in Caribou Biosciences in Q1 2022 and has held it in 9 quarters since.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.